Relevant bibliographies by topics / Neuroprotective agents / Books
To see the other types of publications on this topic, follow the link: Neuroprotective agents.

Books on the topic 'Neuroprotective agents'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 August 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Neuroprotective agents.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

International Conference on Neuroprotective Agents: Clinical and Experimental Aspects (8th 2006 Mackinac Island, Mich.). Neuroprotective agents. Edited by Slikker William, Andrews Russell J, Trembly Bruce, and New York Academy of Sciences. Malden, MA: Blackwell Pub. on behalf of the New York Academy of Sciences, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

William, Slikker, Trembly Bruce, and International Conference on Neuroprotective Agents: Clinical and Experimental Aspects (5th ; : 2000 : Lake Tahoe, Nev.), eds. Neuroprotective agents: Fifth international conference. New York, N.Y: New York Academy of Sciences, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

William, Slikker, and Trembly Bruce, eds. Neuroprotective agents: Third international conference. New York: New York Academy of Sciences, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

International Conference on Neuroprotective Agents: Clinical and Experimental Aspects (9th 2008 Woods Hole, Mass.). Neuroprotective agents: Ninth international conference. Edited by Andrews Russell J. New York: New York Academy of Sciences, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

López-Muñoz, Francisco, Venkataramanujam Srinivasan, Domenico de Berardis, Cecilio Álamo, and Takahiro A. Kato, eds. Melatonin, Neuroprotective Agents and Antidepressant Therapy. New Delhi: Springer India, 2016. http://dx.doi.org/10.1007/978-81-322-2803-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bruce, Trembly, Slikker William, and International Conference on Neuroprotective Agents: Clinical and Experimental Aspects (2nd : 1994 : Lake George, N.Y.), eds. Neuroprotective agents: Clinical and experimental aspects. New York: New York Academy of Sciences, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

V, Borlongan Cesario, Isacson Ole, and Sanberg Paul R, eds. Immunosuppressant analogs in neuroprotection. Totowa, N.J: Humana Press, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

V, Borlongan Cesario, Isacson Ole, and Sanberg Paul R, eds. Immunosuppressant analogs in neuroprotection. Totowa, N.J: Humana Press, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

V, Borlongan Cesario, Isacson Ole, and Sanberg Paul R, eds. Immunosuppressant analogs in neuroprotection. Totowa, N.J: Humana Press, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Jain, K. K. The handbook of neuroprotection. New York: Humana Press, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Lester, Packer, ed. Micronutrients and brain health. Boca Raton: Taylor & Francis, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Flint, Beal M., Marcoux Frank W. 1952-, and Choi D. W, eds. CNS neuroprotection. Berlin: Springer, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Johns, Lisa. Amino acid transmitter release and the use of neuroprotective agents in models of brain ischaemia. Birmingham: University of Birmingham, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

A, Levin Leonard, and Di Polo Adriana, eds. Ocular neuroprotection. New York: Marcel Dekker, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

C, Collin, ed. Advances in neuroregulation and neuroprotection. Leiden: VSP, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Abel, Lajtha, and Vécsei Lázló, eds. Frontiers in clinical neuroscience: Neurodegeneration and neuroprotection : a symposium in Abel Lajtha's honour. New York: Kluwer Academic/Plenum Publishers, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Mishra, Om P. Mechanisms of hypoxic brain injury in the newborn and potential strategies for neuroprotection. Trivandrum,Kerala, India: Transworld Research Network, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Ahmet, Höke, ed. Erythropoietin and the nervous system: Novel therapeutic options for neuroprotection. New York, NY: Springer, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

M, Alves Wayne, and Skolnick Brett Evan, eds. Handbook of neuroemergency clinical trials. Burlington, MA: Elsevier Academic Press, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Perrott, Jerrold L., and Steven C. Reynolds. Neuroprotective agents in critical illness. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0048.

Full text
Abstract:
The prevention and reduction of secondary injury following primary CNS insult is an important goal in critically-ill patients. Numerous pharmacological therapies have been studied as potential neuroprotective agents with few translating from research to clinical benefit. These are nimodipine and statins in aneurysmal subarachnoid haemorrhage and phenytoin in traumatic brain injury. Additionally, in traumatic brain injury, clinical studies have identified that corticosteroids and albumin colloid resuscitation are associated with increased risk of mortality, and as such should be avoided. Future research into new pharmacological neuroprotective strategies is warranted.
APA, Harvard, Vancouver, ISO, and other styles
21

Jenner, Peter, Richard C. Green, Ronald J. Bradley, Robert Adron Harris, and Alan J. Cross. Neuroprotective Agents and Cerebral Ischaemia. Elsevier Science & Technology Books, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

López-Muñoz, Francisco, Venkataramanujam Srinivasan, Domenico de Berardis, Cecilio Álamo, and Takahiro A. Kato. Melatonin, Neuroprotective Agents and Antidepressant Therapy. Springer, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

López-Muñoz, Francisco, Venkataramanujam Srinivasan, Domenico de Berardis, Cecilio Álamo, and Takahiro A. Kato. Melatonin, Neuroprotective Agents and Antidepressant Therapy. Springer (India) Private Limited, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

López-Muñoz, Francisco, Venkataramanujam Srinivasan, Domenico de Berardis, Cecilio Álamo, and Takahiro A. Kato. Melatonin, Neuroprotective Agents and Antidepressant Therapy. Springer London, Limited, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

(Editor), Jr William Slikker, and Bruce Trembly (Editor), eds. Neuroprotective Agents-Fifthe International Conference (Volume 939). The New York Academy of Sciences, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

Discovery and Development of Neuroprotective Agents from Natural Products. Elsevier, 2017. http://dx.doi.org/10.1016/c2014-0-04884-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Brahmachari, Goutam. Discovery and Development of Neuroprotective Agents from Natural Products. Elsevier, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

Brahmachari, Goutam. Discovery and Development of Neuroprotective Agents from Natural Products. Elsevier Science & Technology Books, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

(Editor), William Slikker, Russell J. Andrews (Editor), and Bruce Trembly (Editor), eds. Neuroprotective Agents: Eighth International Neuroprotection Society Meeting (Annals of the New York Academy of Sciences). Wiley-Blackwell, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

Innate Tolerance In The Cns Translational Neuroprotection By Pre And Postconditioning. Springer, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Immunosuppressant Analogs in Neuroprotection. Humana Press, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

Ritsner, Michael S. Brain Protection in Schizophrenia, Mood and Cognitive Disorders. Springer, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

(Editor), Richard C. Green, Alan J. Cross (Editor), Ronald J. Bradley (Series Editor), Robert Adron Harris (Series Editor), and Peter Jenner (Series Editor), eds. Neuroprotective Agents and Cerebral Ischaemia, Volume 40 (International Review of Neurobiology.). Academic Press, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

(Editor), Richard C. Green, Alan J. Cross (Editor), Ronald J. Bradley (Series Editor), Robert Adron Harris (Series Editor), and Peter Jenner (Series Editor), eds. Neuroprotective Agents and Cerebral Ischaemia, Volume 40 (International Review of Neurobiology.). Academic Press, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Neuropeptides in neuroprotection and neuroregeneration. Boca Raton, FL: CRC Press, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

Hodgkiss, Andrew. Psychiatric consequences of cancer treatments: ‘small molecule’ molecularly targeted agents. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198759911.003.0008.

Full text
Abstract:
The psychiatric consequences of a range of small-molecule, molecularly targeted systemic treatments for cancer are reviewed. Psychopathology may arise from the endocrine complications of VEGFR/multiple TK inhibitors. The mechanisms by which PI3K/AKT inhibition and proteasome inhibition can provoke anxiety and depressive phenomena in animals and humans are discussed. PARP-1 inhibition impairs memory acquisition in animal models and is neuroprotective. PARP-2 inhibitors display anti-neuroinflammatory properties in mice. The cognitive enhancing, mood stabilizing, and neuroprotective effects of HDAC inhibitors are considered.
APA, Harvard, Vancouver, ISO, and other styles
37

(Editor), William Slikker, and Russell J. Andrews (Editor), eds. Neuroprotective Agents: Seventh International Conference (Annals of the New York Academy of Sciences). New York Academy of Sciences, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
38

Tissueprotective Cytokines Methods And Protocols. Humana Press Inc., 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

Pitcher, Joseph H., and David B. Seder. Neuroprotection for Cardiac Arrest. Edited by David L. Reich, Stephan Mayer, and Suzan Uysal. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190280253.003.0009.

Full text
Abstract:
This chapter reviews the pathophysiology of brain injury after resuscitation from cardiac arrest and describes a pragmatic approach to neuroprotection. Common mechanisms of brain injury in the postresuscitation milieu are discussed and strategies for optimizing physiological variables such as blood pressure, oxygen, ventilation, and blood glucose in order to minimize secondary injury are presented. Neuroprotective therapies, such as targeted temperature management and pharmacologic neuroprotective agents, are covered in detail. Finally, the use of raw and processed electroencephalography and other diagnostic tools are described for the purposes of determining severity of brain injury, triaging patients to different treatment pathways, and for prognostic value.
APA, Harvard, Vancouver, ISO, and other styles
40

Neuroprotection in neurodegeneration. Wien: Springer-Verlag, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
41

Tahoe, Nev ). International Conference on Neuroprotective Agents: Clinical and Experimental Aspects (5th ;. 2000 :. Lake. Neuroprotective Agents: 5th International Conference (Annals of the New York Academy of Sciences). New York Academy of Sciences, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
42

(Editor), Bruce Trembly, and William Slikker (Editor), eds. Neuroprotective Agents: Fourth International Conference (Annals of the New York Academy of Sciences). New York Academy of Sciences, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
43

(Editor), William Slikker, and Bruce Trembly (Editor), eds. Neuroprotective Agents: Third International Conference (Annals of the New York Academy of Sciences). New York Academy of Sciences, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
44

(Editor), William Slikker, Russell J. Andrews (Editor), and Bruce Trembly (Editor), eds. Neuroprotective Agents: 6th International Conference (Annals of the New York Academy of Sciences). New York Academy of Sciences, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
45

Shillcutt, Samuel D., Venkatramanujan Srinivasan, Gabriella Gobbi, and Sibel Suzen. Melatonin: Therapeutic Value and Neuroprotection. Taylor & Francis Group, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
46

Shillcutt, Samuel D., Venkatramanujan Srinivasan, Gabriella Gobbi, and Sibel Suzen. Melatonin: Therapeutic Value and Neuroprotection. Taylor & Francis Group, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
47

Shillcutt, Samuel D., Venkatramanujan Srinivasan, Gabriella Gobbi, and Sibel Suzen. Melatonin: Therapeutic Value and Neuroprotection. Taylor & Francis Group, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
48

George, N. Y. ). International Conference on Neuroprotective Agents: Clinical and Experimental Aspects (2nd :. 1994 :. Lake. Neuroprotective Agents: Clinical and Experimental Aspects (Annals of the New York Academy of Sciences). New York Academy of Sciences, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
49

(Editor), Richard C. Green, Alan J. Cross (Editor), Ronald J. Bradley (Series Editor), Robert Adron Harris (Series Editor), and Peter Jenner (Series Editor), eds. Intl Reveiw of Neurobiology: Neuroprotective Agents & Cerebral Ischaemia, Volume 40 (International Review of Neurobiology). Academic Press, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
50

(Editor), Richard C. Green, Alan J. Cross (Editor), Ronald J. Bradley (Series Editor), Robert Adron Harris (Series Editor), and Peter Jenner (Series Editor), eds. Intl Reveiw of Neurobiology: Neuroprotective Agents & Cerebral Ischaemia, Volume 40 (International Review of Neurobiology). Academic Press, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Neuroprotective agents' for other source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography